Global Cannabis Applications Corp. (
CSE: C.APP,
OTCQB: FUAPF,
Forum) said Wednesday it will participate in a medical cannabis study on the effects of cannabis on mental health conducted by Dr. Alasdair Barr.
The study, to be conducted at the University of British Columbia, will be applied using semi-structured clinical interviews with instruments commonly applied to clinical trials in order to investigate a population of people in Vancouver, B.C, who suffer from metal health issues and choose to self-medicate with medical cannabis.
More information can be found
here.
Global Cannabis was in the news recently when it announced the launch of Global Cannabis Apps Corp. (GCAC), a private Australian company held 61% by Global Cannabis, which in turn is based in Vancouver.
FULL DISCLOSURE: Global Cannabis Applications Corp. is a paid client of Stockhouse Publishing.